Liquidia Corp (LQDA)

$13.62 0.19 (1.38%)

13:02 EDT LQDA Stock Quote Delayed 30 Minutes

Hero or Zero? 7 High-Risk Stocks to Make You Rich… Or Broke.

By Thomas Niel, InvestorPlace Contributor May 21, 2023

Company-specific catalysts still stand to make (or break) these seven high-risk stocks. Each one could ultimately rocket to the moon, or fall to the depths of the stock market graveyard.

Insider Buying 2022: 15 Stocks to Bet On Despite the Bear Market

7 Momentum Stocks to Buy Now for Extraordinary Gains

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

Volume:

Previous Close -

Market Cap 1.04B

PE Ratio -11.35

EPS -1.2

Volume (Avg. Vol.) 220,119

Day's Range $13.41 - $13.97

52-Week Range $5.71 - $16.99

Dividend & Yield N/A (N/A)

LQDA Stock Predictions, Articles, and Liquidia Corp News

From InvestorPlace
From the Web

7 Stocks to Watch for Major Insider Trading Clues

By Brian Paradza, CFA Apr 27, 2022

These seven stocks show varying degrees of insider trading, which can provide a hint regarding each company or fund's performance.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

By William White, InvestorPlace Writer Apr 13, 2022

Rise and shine, trader! Join me today as we break down all the news behind the biggest pre-market stock movers for Wednesday!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

By William White, InvestorPlace Writer Oct 11, 2021

Welcome back, traders! We're kicking off the week right with a look at the biggest pre-market stock market movers for Monday!

7 Micro-Cap Stocks You May Want to Take a Chance On

By Chris Lau, InvestorPlace Contributor Jul 21, 2020

When Wall Street ignores micro-cap stocks, it creates deep value opportunities, if a company is able to turn things around against fortune.

Liquidia stock slips as FDA delays review for Yutrepia

From Seeking Alpha Jan 25, 2024

The U.S. FDA has extended the review period for Liquidia Corporation's (LQDA) request to add a new indication for its drug-device combination Yutrepia. Read more here.

Liquidia announces updates to operations leadership (NASDAQ:LQDA)

From Seeking Alpha Jan 19, 2024

Liquidia (LQDA) announces promotions to its operations leadership, including Michael Kaseta as new COO/CFO, ahead of YUTREPIA launch.

Liquidia stock jumps after company announces $100M in new financings (NASDAQ:LQDA)

From Seeking Alpha Jan 4, 2024

Liquidia (LQDA) secures $100M in additional capital from transactions with Patient Square Capital and HealthCare Royalty, propelling shares up 7.8%.

MarketBeat Week in Review: 12/25 - 12/29

From MarketBeat Dec 30, 2023

The Santa Claus rally took the S&P 500 up about 0.75%, but recession concerns linger as the full impact of the Fed's rate hikes hasn't hit the economy.

Liquidia files for a $200M mixed securities shelf (NASDAQ:LQDA)

From Seeking Alpha Dec 28, 2023

Liquidia (LQDA) files prospectus for $200M mixed shelf offering, not an offer to sell securities.

Wedbush Remains a Sell on Liquidia Technologies (LQDA)

From TipRanks Nov 9, 2022

Wedbush analyst Andreas Argyrides reiterated a Sell rating on Liquidia Technologies (LQDA – Research Report) today and set a price target of $3.00. The compan...

Liquidia Corp (LQDA)

Hero or Zero? 7 High-Risk Stocks to Make You Rich… Or Broke.

Insider Buying 2022: 15 Stocks to Bet On Despite the Bear Market

7 Momentum Stocks to Buy Now for Extraordinary Gains

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Liquidia Corp (LQDA)

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

LQDA Stock Predictions, Articles, and Liquidia Corp News

Subscriber Sign in